Hims & Hers Health Inc. (HIMS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals.
The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers.
It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care.
The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category.
In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners.
The company is based in San Francisco, California.
Country | United States |
IPO Date | Sep 13, 2019 |
Industry | Household & Personal Products |
Sector | Consumer Defensive |
Employees | 1,046 |
CEO | Andrew Dudum |
Contact Details
Address: 2269 Chestnut Street San Francisco, California United States | |
Website | https://www.forhims.com |
Stock Details
Ticker Symbol | HIMS |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001773751 |
CUSIP Number | 433000106 |
ISIN Number | US4330001060 |
Employer ID | 00-0000000 |
SIC Code | 8011 |
Key Executives
Name | Position |
---|---|
Andrew Dudum | Co-Founder, Chairman & Chief Executive Officer |
Melissa Baird | Chief Operating Officer |
Soleil Teubner Boughton J.D. | Chief Legal Officer & Corporate Secretary |
Yemi Okupe | Chief Financial Officer |
Amee Parekh | Senior Vice President of Human Resources |
Dr. Patrick Carroll M.D. | Chief Medical Officer, Member of Medical Advisory Board & Director |
Dr. Peter Stahl M.D. | Senior Vice President & Member of Medical Advisory Board |
Irene A. Becklund | Senior Vice President, Controller & Principal Accounting Officer |
Khobi Brooklyn | Chief Communications Officer |
Mike Chi | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 24, 2025 | 4 | Filing |
Jan 24, 2025 | 4 | Filing |
Jan 23, 2025 | 4 | Filing |
Jan 23, 2025 | 4 | Filing |
Jan 23, 2025 | 4 | Filing |
Jan 23, 2025 | 4 | Filing |
Jan 23, 2025 | 4/A | [Amend] Filing |
Jan 21, 2025 | 4 | Filing |
Jan 14, 2025 | 4 | Filing |
Jan 14, 2025 | 4 | Filing |